HPV genotype prevalence in cervical specimens with abnormal cytology: A report from north-east Italy

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 6-7, 2005, Pages 476-481

  Rassu, Mario ^a   Bertoloni, Giulio ^b   Mengoli, Carlo ^b   Peron, Antonella ^a   Benedetti, Paolo ^c   Palu, Giorgio ^b  

^a San Bartolo Hospital   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

AGE; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DNA DETERMINATION; ETHNOLOGY; FEMALE; GENOTYPE; HUMAN; IMMIGRATION; ITALY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; RISK ASSESSMENT; SCREENING TEST; SQUAMOUS CELL; SQUAMOUS EPITHELIUM; UTERINE CERVIX BIOPSY; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; CERVIX UTERI; FEMALE; GENOTYPE; HUMANS; ITALY; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; UTERINE CERVICAL DISEASES;

EID: 22844442423     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540510036633     Document Type: Article

References (14)

1. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000;87:221-7.
2. Lowy DR, Howley PM. Papillomaviruses. In: Knipe DM, Howley PM, editors. Fields Virology, 4th edn. Lippincott, Williams and Wilkins; 2001. p. 2231-64.
3. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994;186:131-56.
4. Sahebali S, Depuydt CE, Segers K, Vereecken AJ, Bogers JJ. Cervical cytological screening and human papillomavirus DNA testing in Flanders. Acta Clin Belg 2003;58: 211-9.
5. Voglino G, Poso F, Privitera S, Parisio F, Ghiringhello B, Gordini G, et al. Il ruolo del papillomavirus umano (HPV) nella pratica cito-istologica: distribuzione e prevalenza dei ceppi ad alto rischio (16, 18, 31, 33 e 35) nelle lesioni intraepiteliali e nelle neoplasie della cervice uterina. Pathologica 2000;92:516-23.
6. Chan PK, Chang AR, Cheung JL, Chan DP, Xu LY, Tang NL, Cheng AF. Determinants of cervical human papillomavirus infection: differences between high- and low-oncogenic risk types. J Infect Dis 2002;185:28-35.
7. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delins H, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. JID 1994; 170:1077-85.
8. Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001;183:1554-64.
9. Tarkowski TA, Koumans EH, Sawyer M, Pierce A, Black CM, Papp JR, et al. Epidemiology of human papillomavirus infection and abnormal cytological test results in an urban adolescent population. JID 2004;189:46-50.
10. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-74.
11. Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 2003;127:930-4.
12. Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1992;84:394-8.
13. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003;16:1-17.
14. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al., for the GlaxoSmithKline HPV Vaccine Study Group. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 2004;364:1757-65.